More Than 200 Companies Advance Trial Management with Veeva CTMS

Biopharmas use leading CTMS for improved trial efficiency and collaboration BARCELONA, Spain, Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute faster, more efficient trials. As study complexity and data volumes increase, biopharmas and CROs are centralizing data and documents with Veeva CTMS to streamline processes and drive stakeholder collaboration. "Veeva CTMS is the central hub of our ...